SUMMARY One of 4 antibiotics with antistaphylococcal activity was given in a conventional oral dose for one day to each of 20 hospitalised patients with synovial effusion of a knee joint requiring aspiration. Serial synchronous samples of serum and synovial fluid (SF) were taken over 36 hours through indwelling cannulae. No morbidity was experienced either during or after this procedure. Satisfactory antistaphylococcal concentrations in SF were achieved with sodium fusidate (500 mg 8 hourly) and amoxycillin (250 mg 8 hourly). Cephradine (500 mg 6 hourly) frequently failed to reach the minimum inhibitory concentration for Staphylococcus aureus in the SF, and flucloxacillin (250 mg 6 hourly) was unpredictable in its penetration of the synovial space. Wide interpatient variation of both serum and SF concentrations was found. Our results indicate that sodium fusidate is an appropriate early treatment for a nonresistant staphylococcal joint infection. Amoxycillin is a suitable alternative or second antistaphylococcal drug and would also be appropriate initial therapy when the infecting organism is unknown. We strongly recommend that SF antibiotic concentrations be measured, to ensure adequate penetration of the synovial cavity, in the treatment of septic arthritis.
Septic arthritis is an important complication of preexisting joint disease, especially rheumatoid arthritis.`-3 Since Kellgren and his colleagues4 first emphasised the morbidity and potential high mortality of pyogenic infection of rheumatoid joints about 100 Patients were given one or 2 of these antibiotics in conventional dosage by mouth for one day, as follows: amoxycillin 250 mg 8 hourly, 7 subjects; cephradine 500 mg 6 hourly, 6 subjects; flucloxacillin 250 mg 6 hourly, 6 subjects; sodium fusidate 500 mg 8 hourly, 6 subjects.
Samples of blood (5 ml) and SF (2 ml) were withdrawn immediately before the first dose of antibiotic and then at 30, 45, 60, and 90 minutes and 2, 3, 4, 6, 8, 12, 24, and 36 hours thereafter. After centrifugation the SF and plasma were stored at -70°C until assay. Antibiotic levels were measured by standard agar diffusion microbiological assay.25 Methods used were generally those recommended by the manufacturers, who also provided purified antibiotics used for making standard solutions.
Amoxycillin (Bencard), cephradine (Squibb), and flucloxacillin (Beecham) were assayed on plates flooded with a suspension of Sarcina lutea (NCTC 8340), the samples being contained either in wells in the agar (amoxycillin) or in stainless steel cylinders resting on the surface of the agar (cephradine and flucloxacillin). Sodium fusidate (Leo Laboratories) was assayed on plates seeded with Corynebacterium xerosis and samples were placed in the agar. Two of the earlier patients received both sodium fusidate and flucloxacillin, and it was necessary to remove the antibacterial effects of the second agent when performing the assay in these cases. Flucloxacillin was inhibited by beta lactamase (Whatman) derived from Bacillus cereus at 10 units/ml final concentration, and the action of fucidic acid was overcome by use of a strain of Sarcina lutea (NCTC 8340) trained to a high degree of resistance to this agent. In these cases appropriate controls were included to demonstrate any inhibition due to the other simultaneously administered antibiotic. As a check against blood contamination of SF samples those which were pink tinged were measured spectrophotometrically at 560 nm. The haemoglobin content thus determined was never greater than 1 %YO
Results
The concentrations of the antibiotics in both serum and SF are shown in Figs. 1-5. Figs. [1] [2] [3] [4] show serum and SF antibiotic concentrations as the mean results from 6 patients in each group (with the exception of amoxycillin, which has 7 patients), together with. individual results in SF. Fig. 5 Wide interpatient variation was found in serum and SF with all 4 antibiotics, apparently independent of underlying pathology or severity of inflammation, and no correlation was found between SF concentrations and clinical or laboratory indices of inflammation (Table 1) .
Discussion
Antibiotic concentration in joint fluid must be considered in relation to the concentration needed to eliminate a pathogen. The World Health Organisation (WHO) recommends that the antibiotic concentration should exceed the MIC of the organism by a margin of 2-to 4-fold to ensure that the infection is amenable to treatment.26
It can be seen from the above results that sodium fusidate and amoxycillin rapidly enter the joint fluid of inflamed joints after oral administration in the doses we selected, and these levels approach those in the plasma and are in excess of the in-vitro MICs of those bacteria commonly responsible for pyogenic infection. The SF concentrations of cephradine and flucloxacillin were often inadequate with the doses we employed. Flucloxacillin was unpredictable as to its penetration of SF, achieving concentrations suffciently in excess of the MIC forStaph. aureus in only a minority of subjects. Cephradine penetrated poorly into the SF in some cases and was clearly unsatisfactory in this regard. These results also show that concentrations of antibiotics in SF reach peak levels rather later than in serum and decrease more slowly, and that there are appreciable amounts present in joint fluid up to 12 hours after the last dose of antibiotics, as previously reported from various studies with penicillin in the 1940s.27-29 Our study confirms the results of previous workers that with the possible exception of sodium fusidate, which has an enterohepatic recirculation, there is with these doses no accumulation of antibiotics in joint fluid, although they disappear more slowly than from the serum. Our study also demonstrates wide interpatient variability in the joint fluid antibiotic concentrations as well as changes related to time and dosage. This is a reflection of wide variation in serum concentrations, a common finding in pharmacokinetic studies with many antibiotic compounds. Most 
